ECMO Machine Market to Reach $673 Million by 2026
According to research report the ECMO Machine Market was valued at $531 million in 2021 and is expected to reach $673 million by 2026, growing at a compound annual growth rate of 4.9% during that period. ECMO machines provide prolonged cardiac and respiratory support to critically ill patients.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255167654
The
growth of this market is driven primarily by the expanding geriatric
population and increasing prevalence of chronic respiratory diseases and
cardiovascular diseases globally. For instance, chronic obstructive
pulmonary disease (COPD) is the third leading cause of death worldwide.
ECMO machines are increasingly being used in lung transplantation
procedures as well, especially for patients with severe acute
respiratory distress syndrome (ARDS).
Technological advancements
have significantly contributed to the increased adoption of ECMO
machines, enabling faster and more precise diagnosis and treatment
compared to older equipment. However, challenges such as high costs
associated with ECMO therapies, limited healthcare budgets in developing
countries, and declining insurance reimbursements remain impediments to
widespread adoption.
Despite these challenges, the rising
utilization of ECMO machines has led to improved survival rates for
critical cardiac and respiratory cases, presenting promising
opportunities for manufacturers and medical providers. Development of
portable and user-friendly ECMO devices, along with training programs to
enhance the pool of qualified ECMO specialists, are avenues for market
expansion.
The respiratory care segment holds the largest market
share, driven by the growing prevalence of pulmonary diseases, while
arterio-venous ECMO modalities dominate due to their dynamic range and
diagnostic value. Usage of ECMO machines for adults accounts for the
greatest market share, particularly benefiting older patients with heart
and lung failure.
Geographically, the Asia-Pacific region is
expected to witness the fastest growth rate in the ECMO machine market,
attributed to factors such as the expanding elderly population, rising
disposable incomes, and supportive government policies.
Leading
players in the global ECMO machine market, including Getinge Group,
Medtronic, Fresenius Medical Care, Microport, and Terumo Cardiovascular
Systems Corporation, are focusing on new product development and
partnerships to enhance competitiveness. Regulatory approvals for new
ECMO devices in key markets such as the U.S. and China underscore
ongoing innovations in the field.
Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=255167654
In
conclusion, the combination of increasing chronic cardiovascular and
respiratory illnesses globally, coupled with technological advancements,
is driving growth in the ECMO machine market. While challenges persist,
companies are investing in research, development, and geographic
expansion to capitalize on this market's strong growth potential in the
coming years.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
Comments
Post a Comment